Clinical trials
Phase 1 Overweight trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 5 |
| Not yet recruiting | 3 |
| Suspended | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Zafgen, Inc. | 3 |
| Shanghai Minwei Biotechnology Co., Ltd | 2 |
| Allysta Pharmaceutical | 1 |
| Bayside Health | 1 |
| Biomed Industries, Inc. | 1 |
| CSPC Megalith Biopharmaceutical Co.,Ltd. | 1 |
| Carmot Australia First Pty Ltd | 1 |
| Gmax Biopharm Australia Pty Ltd. | 1 |
| Helicore Biopharma, Inc. | 1 |
| HongKong Curegene Innovation Co., Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 20 |
| Obesity | 18 |
| Diabetes Mellitus, Type 2 | 2 |
| Heart Failure | 1 |
| Insulin Resistance | 1 |
| Weight Loss | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.